Arkansas Legal Resource Navigator

22 U.S.C. § 2291k — Untitled legal text

Federal law — U.S. Code and appendices · legal_authorities

22 U.S.C. § 2291k — Untitled legal text

Page 748 TITLE 22—FOREIGN RELATIONS AND INTERCOURSE § 2291k Determination of President of the United States, No. 2013–14, Sept. 13, 2013, 78 F.R. 58855. Determination of President of the United States, No. 2012–15, Sept. 14, 2012, 77 F.R. 58917. Determination of President of the United States, No. 2011–16, Sept. 15, 2011, 76 F.R. 59495. Determination of President of the United States, No. 2010–16, Sept. 15, 2010, 75 F.R. 67019, 68413. Determination of President of the United States, No. 2009–30, Sept. 15, 2009, 74 F.R. 48369. Determination of President of the United States, No. 2008–28, Sept. 15, 2008, 73 F.R. 54927. Determination of President of the United States, No. 2007–33, Sept. 14, 2007, 43 Weekly Compilation of Presi- dential Documents 1216, Sept. 24, 2007. Determination of President of the United States, No. 2006–24, Sept. 15, 2006, 71 F.R. 57865. Determination of President of the United States, No. 2005–36, Sept. 14, 2005, 70 F.R. 56807. Determination of President of the United States, No. 2004–47, Sept. 15, 2004, 69 F.R. 57809. Determination of President of the United States, No. 2003–38, Sept. 15, 2003, 68 F.R. 54973. Determination of President of the United States, No. 2003–14, Jan. 30, 2003, 68 F.R. 5787. PRESIDENTIAL DETERMINATION ON WAIVING A RESTRIC- TION ON UNITED STATES ASSISTANCE TO BOLIVIA UNDER SECTION 706 OF THE FOREIGN RELATIONS AUTHORIZA- TION ACT, FISCAL YEAR 2003 Determination of President of the United States, No. 2020–05, Jan. 6, 2020, 85 F.R. 6731, provided: Memorandum for the Secretary of State By the authority vested in me as President by the Constitution and the laws of the United States, includ- ing section 706(3)(A) of the Foreign Relations Author- ization Act, Fiscal Year 2003 (Public Law 107–228) (FRAA)

Source: Supplied 2024 U.S. Code historical extraction · 22 U.S.C. § 2291k

Stored review status: historical_2024_not_currentness_verified. A text match is a research starting point; applicability is not established.

Original supplied file — preserved unchanged

Download original Markdown file

File SHA-256: b93ba719a34bed2ac4795752f2e5d5b5a5c0b3d5318891af9f700fe5cb73879c. The original may include catalog metadata, neighboring provisions, or embedded records outside this collection's scope. Search shows only the selected federal record. Historical editions and unverified snapshots are not a statement of current law.

Authority boundary: historical or unconfirmed source not current law verified.

Open the recorded source website ↗

Record provenance

Stable record: federal_law:legal_authorities:usc2024-dda3a0b87928a24f15cb2562
Source file: Laws/federal/codes/united-states-code-2024/title-22/section-2291k-untitled-legal-text--2aeeb85341.md
Pages: Not recorded – Not recorded
Passage SHA-256: f3081743931b3b53bb43ceb29d8d306aedd37bc02ea5bfffe5c0117d18697cfc

Source location: USCODE-2024-title22-chap32-subchapI-partVIII-sec2291k.pdf

Stored source content

Page 748 TITLE 22—FOREIGN RELATIONS AND INTERCOURSE § 2291k Determination of President of the United States, No. 2013–14, Sept. 13, 2013, 78 F.R. 58855. Determination of President of the United States, No. 2012–15, Sept. 14, 2012, 77 F.R. 58917. Determination of President of the United States, No. 2011–16, Sept. 15, 2011, 76 F.R. 59495. Determination of President of the United States, No. 2010–16, Sept. 15, 2010, 75 F.R. 67019, 68413. Determination of President of the United States, No. 2009–30, Sept. 15, 2009, 74 F.R. 48369. Determination of President of the United States, No. 2008–28, Sept. 15, 2008, 73 F.R. 54927. Determination of President of the United States, No. 2007–33, Sept. 14, 2007, 43 Weekly Compilation of Presi- dential Documents 1216, Sept. 24, 2007. Determination of President of the United States, No. 2006–24, Sept. 15, 2006, 71 F.R. 57865. Determination of President of the United States, No. 2005–36, Sept. 14, 2005, 70 F.R. 56807. Determination of President of the United States, No. 2004–47, Sept. 15, 2004, 69 F.R. 57809. Determination of President of the United States, No. 2003–38, Sept. 15, 2003, 68 F.R. 54973. Determination of President of the United States, No. 2003–14, Jan. 30, 2003, 68 F.R. 5787. PRESIDENTIAL DETERMINATION ON WAIVING A RESTRIC- TION ON UNITED STATES ASSISTANCE TO BOLIVIA UNDER SECTION 706 OF THE FOREIGN RELATIONS AUTHORIZA- TION ACT, FISCAL YEAR 2003 Determination of President of the United States, No. 2020–05, Jan. 6, 2020, 85 F.R. 6731, provided: Memorandum for the Secretary of State By the authority vested in me as President by the Constitution and the laws of the United States, includ- ing section 706(3)(A) of the Foreign Relations Author- ization Act, Fiscal Year 2003 (Public Law 107–228) (FRAA) [22 U.S.C. 2291j–1(3)(A)], I hereby determine that the provision of United States assistance to Bo- livia in Fiscal Year 2020 is vital to the national inter- ests of the United States. You are authorized and directed to submit this deter- mination, with its memorandum of justification, under section 706 of the FRAA, to the Congress, and to pub- lish it in the Federal Register. DONALD J. TRUMP. § 2291k. Repealed. Pub. L. 104–66, title I, § 1112(b), Dec. 21, 1995, 109 Stat. 724 Section, Pub. L. 87–195, pt. I, § 490A, as added Pub. L. 102–583, § 5(a), Nov. 2, 1992, 106 Stat. 4927; amended Pub. L. 103–447, title I, § 101(g)(2), Nov. 2, 1994, 108 Stat. 4693, related to annual certification procedures after Sept. 30, 1995. § 2291l. Prioritization of efforts of the Depart- ment of State to combat international traf- ficking in covered synthetic drugs (a) In general The Secretary of State shall prioritize efforts of the Department of State to combat inter- national trafficking of covered synthetic drugs by carrying out programs and activities to in- clude the following: (1) Supporting increased data collection by the United States and foreign countries through increased drug use surveys among populations, increased use of wastewater test- ing where appropriate, and multilateral shar- ing of that data. (2) Engaging in increased consultation and partnership with international drug agencies, including the European Monitoring Centre for Drugs and Drug Addiction, regulatory agen- cies in foreign countries, and the United Na- tions Office on Drugs and Crime. (3) Carrying out programs to provide tech- nical assistance and equipment, as appro- priate, to strengthen the capacity of foreign law enforcement agencies with respect to cov- ered synthetic drugs, as required by section 2291m of this title. (4) Carrying out exchange programs for gov- ernmental and nongovernmental personnel in the United States and in foreign countries to provide educational and professional develop- ment on demand reduction matters relating to the illicit use of covered synthetic drugs and other drugs, as required by section 2291n of this title. (b) Report (1) In general Not later than one year after December 23, 2022, the Secretary of State shall submit to the appropriate congressional committees a report on the implementation of this section. (2) Appropriate congressional committees de- fined In this subsection, the term ‘‘appropriate congressional committees’’ means— (A) the Committee on Foreign Relations, the Committee on Appropriations, and the Committee on the Judiciary of the Senate; and (B) the Committee on Foreign Affairs, the Committee on Appropriations, and the Com- mittee on the Judiciary of the House of Rep- resentatives. (Pub. L. 117–263, div. E, title LV, § 5552, Dec. 23, 2022, 136 Stat. 3341.) Editorial Notes CODIFICATION Section was enacted as part of the Fighting Emerging Narcotics Through Additional Nations to Yield Lasting Results Act, also known as the FENTANYL Results Act, and also as part of the James M. Inhofe National Defense Authorization Act for Fiscal Year 2023, and not as part of the Foreign Assistance Act of 1961 which comprises this chapter. Statutory Notes and Related Subsidiaries RULE OF CONSTRUCTION Pub. L. 117–263, div. E, title LV, § 5557, Dec. 23, 2022, 136 Stat. 3344, provided that: ‘‘Nothing in this subtitle [subtitle C (§§ 5551–5558) of title LV of div. E of Pub. L. 117–263, see Short Title of 2022 Amendment note set out under section 2151 of this title] or the amendments made by this subtitle shall be construed to affect the prioritization of extradition requests.’’ DEFINITIONS Pub. L. 117–263, div. E, title LV, § 5558, Dec. 23, 2022, 136 Stat. 3344, provided that: ‘‘In this subtitle [subtitle C (§§ 5551–5558) of title LV of div. E of Pub. L. 117–263, see Short Title of 2022 Amendment note set out under section 2151 of this title]: ‘‘(1) CONTROLLED SUBSTANCE; CONTROLLED SUB- STANCE ANALOGUE.—The terms ‘controlled substance’ and ‘controlled substance analogue’ have the mean- ings given those terms in section 102 of the Con- trolled Substances Act (21 U.S.C. 802). ‘‘(2) COVERED SYNTHETIC DRUG.—The term ‘covered synthetic drug’ means— ‘‘(A) a synthetic controlled substance or syn- thetic controlled substance analogue, including fentanyl or a fentanyl analogue; or

Cross-references

Connections may be documented source relationships, shared citations or nearby passages. Each explains its basis; a connection alone does not establish applicability to your situation.

Federal law — U.S. Code and appendices · legal_authorities

21 U.S.C. § 802 — Definitions

As used in this subchapter: (1) The term “addict” means any individual who habitually uses any narcotic drug so as to endanger the public morals, health, safety, or welfare, or who is so far addicted to the use of narcotic drugs as to have lost the power of self-control with reference to his addiction. (2) The term “administer” refers to the direct application of a controlled substance to the body of a patient or research subject by— (A) a practitioner (or, in his presence, by his authorized agent), or (B) the patient or research subject at the direction and in the presence of the practitioner, whether such application be by injection, inhalation, ingestion, or any other means. (3) The term “agent” means an authorized person who acts on behalf of or at the direction of a manufacturer, distributor, or dispenser; except that such term does not include a common or contract carrier, public warehouseman, or employee of the carrier or warehouseman, when acting in the usual and lawful course of the carrier’s or warehouseman’s business. (4) The term “Drug Enforcement Administration” means the Drug Enforcement Administration in the Department of Justice. (5) The term “control” means to add a drug or other substance, or immediate precursor, to a schedule under part B of this subchapter, whether by transfer from another schedule or otherwise. (6) The term “controlled substance” means a drug or other substance, or immediate precursor, included in schedule I, II, III, IV, or V of part B of this subchapter. The term does not include distilled spirits, wine, malt beverages, or tobacco, as those terms are defined or used in subtitle E of the Internal Revenue Code of 1986. (7) The term “counterfeit substance” means a controlled substance which, or the container or labelin

Source: Supplied U.S. Code snapshot — release unconfirmed · 21 U.S.C. § 802

Stored review status: release_metadata_unconfirmed. The source passage cites 21 U.S.C. § 802. This identifies an authority to review, not proof of applicability.

Federal law — U.S. Code and appendices · legal_authorities

21 U.S.C. § 802 — Definitions

Page 782 TITLE 21—FOOD AND DRUGS § 801a ing it into counterfeit opioid pills. Because fentanyl is lethal in even miniscule doses, this is an extremely deadly tactic, as it too often causes users to ingest a fatal amount unknowingly. SEC. 2. Agency Action. The Secretary of Health and Human Services shall, consistent with section 319 of the Public Health Service Act, 42 U.S.C. 247d, consider declaring that the drug demand and opioid crisis de- scribed in section 1 of this memorandum constitutes a Public Health Emergency. Additionally, the heads of executive departments and agencies, as appropriate and consistent with law, shall exercise all appropriate emergency authorities, as well as other relevant au- thorities, to reduce the number of deaths and minimize the devastation the drug demand and opioid crisis in- flicts upon American communities. SEC. 3. General Provisions. (a) Nothing in this memo- randum shall be construed to impair or otherwise af- fect: (i) the authority granted by law to an executive de- partment or agency, or the head thereof; or (ii) the functions of the Director of the Office of Man- agement and Budget relating to budgetary, administra- tive, or legislative proposals. (b) This memorandum shall be implemented con- sistent with applicable law and subject to the avail- ability of appropriations. (c) This memorandum is not intended to, and does not, create any right or benefit, substantive or proce- dural, enforceable at law or in equity by any party against the United States, its departments, agencies, or entities, its officers, employees, or agents, or any other person. (d) The Secretary of Health and Human Services is hereby authorized and directed to publish this memo- randum in the Federal Register. DONALD J. TRUMP. § 801a

Source: Supplied 2024 U.S. Code historical extraction · 21 U.S.C. § 802

Stored review status: historical_2024_not_currentness_verified. The source passage cites 21 U.S.C. § 802. This identifies an authority to review, not proof of applicability.

Federal law — U.S. Code and appendices · legal_authorities

22 U.S.C. § 2291j — Annual certification procedures

**(a) Withholding of bilateral assistance and opposition to multilateral development assistance** (1) **Bilateral assistance** — Fifty percent of the United States assistance allocated each fiscal year in the report required by [section 2413 of this title](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title22-section2413&num=0&edition=prelim) for each major illicit drug producing country, major drug-transit country, or country identified pursuant to clause (i) or (ii) of [section 2291h(a)(8)(A) of this title](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title22-section2291h/a/8/A&num=0&edition=prelim) shall be withheld from obligation and expenditure, except as provided in subsection (b). This paragraph shall not apply with respect to a country if the President determines that its application to that country would be contrary to the national interest of the United States, except that any such determination shall not take effect until at least 15 days after the President submits written notification of that determination to the appropriate congressional committees in accordance with the procedures applicable to reprogramming notifications under [section 2394–1 of this title](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title22-section2394-1&num=0&edition=prelim). (2) **Multilateral assistance** — The Secretary of the Treasury shall instruct the United States Executive Director of each multilateral development bank to vote, on and after March 1 of each year, against any loan or other utilization of the funds of their respective institution to or for any major illicit drug producing country or major drug-transit country (as determined under subsection (h)) or country identified pursuant to clause (i) or (ii) of [section 2291

Source: Supplied U.S. Code snapshot — release unconfirmed · 22 U.S.C. § 2291j

Stored review status: release_metadata_unconfirmed. The source passage cites 22 U.S.C. § 2291j. This identifies an authority to review, not proof of applicability.

Federal law — U.S. Code and appendices · legal_authorities

22 U.S.C. § 2291j — Annual certification procedures

Page 741 TITLE 22—FOREIGN RELATIONS AND INTERCOURSE § 2291j Subsec. (a)(12). Pub. L. 117–263, § 5555(a)(2), added par. (12). 2021—Subsec. (a)(10). Pub. L. 117–81, § 6610(c), added par. (10) relating to separate section that contains iden- tification of the countries that are the most significant sources of illicit fentanyl and fentanyl analogues. Pub. L. 117–81, § 5102(b), added par. (10) relating to sep- arate section that contains an identification of all United States Government-supported units funded by the Bureau of International Narcotics and Law En- forcement Affairs. 2019—Subsec. (a)(9). Pub. L. 116–92 added par. (9). 2006—Subsec. (a)(8). Pub. L. 109–177 added par. (8). 1995—Pub. L. 104–66, § 1112(c)(1), struck out ‘‘for fiscal year 1995’’ after ‘‘Reporting requirements’’ in section catchline. Subsec. (c). Pub. L. 104–66, § 1112(c)(2), struck out heading and text of subsec. (c). Text read as follows: ‘‘This section applies only during fiscal year 1995. Sec- tion 2291i of this title does not apply during that fiscal year.’’ 1994—Pub. L. 103–447, § 101(f)(1)(A), substituted ‘‘for fiscal year 1995’’ for ‘‘for fiscal years 1993 and 1994’’ in section catchline. Subsec. (a). Pub. L. 103–447, § 101(f)(1)(B)(i), sub- stituted ‘‘March 1’’ for ‘‘April 1’’ in introductory provi- sions. Subsec. (a)(3)(B) to (D). Pub. L. 103–447, § 101(f)(1)(B)(ii), redesignated subpars. (C) and (D) as (B) and (C), respectively, and struck out former subpar. (B) which read as follows: ‘‘the significant direct or indi- rect sources of narcotics and psychotropic drugs and other controlled substances significantly affecting the United States;’’. Subsec. (c). Pub. L. 103–447, § 101(f)(1)(D), (E), redesig- nated subsec. (d) as (c) and amended heading and text gen

Source: Supplied 2024 U.S. Code historical extraction · 22 U.S.C. § 2291j

Stored review status: historical_2024_not_currentness_verified. The source passage cites 22 U.S.C. § 2291j. This identifies an authority to review, not proof of applicability.

Federal law — U.S. Code and appendices · legal_authorities

22 U.S.C. § 2291k — Repealed. Pub. L. 104–66, title I, § 1112(b), Dec. 21, 1995, 109 Stat. 724

### Statutory Notes Section, Pub. L. 87–195, pt. I, § 490A, as added Pub. L. 102–583, § 5(a), Nov. 2, 1992, 106 Stat. 4927; amended Pub. L. 103–447, title I, § 101(g)(2), Nov. 2, 1994, 108 Stat. 4693, related to annual certification procedures after Sept. 30, 1995.

Source: Supplied U.S. Code snapshot — release unconfirmed · 22 U.S.C. § 2291k

Stored review status: release_metadata_unconfirmed. Same stored citation; legal effect and authority still require review.